Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Galena Biopharma In (GALE)

0.6201 +0.0352 (+6.0181%)

4/25/2017  12:11pm

Open:

0.5900

Pre. Close:

0.5849

High:

0.6300

Low:

0.5850

Volume:

882,140

Market Cap:

22.27M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.6 - 0.61

0.61 - 0.63

Low:

0.53 - 0.54

0.54 - 0.55

Close:

0.56 - 0.58

0.58 - 0.6

Technical analysis  (as of: 2017-04-25 12:03:54 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 0.75     One year: 0.82

Support:

Support1: 0.55    Support2: 0.46

Resistance:

Resistance1: 0.64    Resistance2: 0.70

Pivot:

0.58

Moving Averages:

MA(5): 0.58     MA(20): 0.60

MA(100): 1.28     MA(250): 9.54

MACD:

MACD(12,26): -0.03     Signal(12,26,9): -0.04

%K %D:

%K(14,3): 29.41     %D(3): 23.78

RSI:

RSI(14): 45.61

52-Week:

High: 49.8020  Low: 0.5300  Change(%): -97.8

Average Vol(K):

3-Month: 2401  10-Days 535

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
GALE has closed below upper band by 30.4%. Bollinger Bands are 88.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to GALE's normal range. The bands have been in this narrow range for 39 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Wed, 12 Apr 2017 17:26:15 GMT
GALE APRIL 14 ALERT: Rosen Law Firm Reminds Galena Biopharma, Inc. Investors ...

Thu, 09 Mar 2017 12:05:30 GMT
Galena Biopharma Engages Canaccord Genuity to Advise on Strategic Alternatives

Mon, 13 Feb 2017 21:32:09 GMT
Galena Biopharma Announces Closing of Public Offering of Common Stock and Warrants

Tue, 21 Feb 2017 21:11:54 GMT
Galena Biopharma Board of Directors Appoints Stephen F. Ghiglieri as Interim ...

Tue, 31 Jan 2017 22:00:22 GMT
Galena Biopharma Announces the Resignation of its President and Chief ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

32.19

Shares Float (M)

27.37

% Held by Insiders

% Held by Institutions

Shares Short (K)

3440

Shares Short Prior Month (K)

2450

Stock Financials

EPS

-2.370

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

Book Value (p.s.)

1.890

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-26.9

Return on Equity (ttm)

-52.7

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.986

Qtrly Earnings Growth

Operating Cash Flow (M)

-44.92

Levered Free Cash Flow (M)

-47.86

FoxReading.com

Valuation

P/E

-0.25

P/E Growth Ratio

0.03

P/BV

0.32

P/S

P/CF

-0.43

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.